How to buy BELLUS Health (BLU) stocks

BELLUS Health is a biotechnology business based in Canada. BELLUS Health shares (BLU) are listed on the Toronto Stock Exchange (TSX) and all prices are listed in Canadian Dollars. BELLUS Health employs 74 staff and has a trailing 12-month revenue of around C$15,000.

Our top picks for where to buy BELLUS Health stock

Buy BELLUS Health stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

BELLUS Health stock price (Toronto Stock Exchange (TSX): BLU)

Use our graph to track the performance of BLU stocks over time.

BELLUS Health stocks at a glance

• Key figures

Information last updated 2023-08-26.

52-week range	C$0.00 - C$0.00
50-day moving average more info button	C$19.54
200-day moving average more info button	C$13.69
Wall St. target price	C$20.66
PE ratio more info button	N/A
Dividend yield more info button	C$0 (0%)
Earnings per share (TTM) more info button	C$-0.96

Is it a good time to buy BELLUS Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

BELLUS Health financials

Revenue TTM	C$15,000
Gross profit TTM	C$16,000
Return on assets TTM	-16.7%
Return on equity TTM	-26.76%
Profit margin	0%
Book value	C$2.91
Market Capitalization more info button	C$2.5 billion
EBITDA more info button	C$-89,987,000

TTM: trailing 12 months

BELLUS Health stock dividends

We're not expecting BELLUS Health to pay a dividend over the next 12 months.

Have BELLUS Health's stocks ever split?

BELLUS Health's stocks were split on a 1:3.6 basis on 18 August 2019 . So if you had owned 3.6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BELLUS Health stocks – just the quantity. However, indirectly, the new 260% higher stock price could have impacted the market appetite for BELLUS Health stocks, which in turn could have impacted BELLUS Health's stock price.

BELLUS Health stock price volatility

Over the last 12 months, BELLUS Health's stocks have ranged in value from as little as C$0 up to C$0. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (TO average) beta is 1, while BELLUS Health's is -0.279. This would suggest that BELLUS Health's stocks have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, BELLUS Health has bucked the trend.

BELLUS Health overview

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of BELLUS Health is owned by insiders or institutions?
Currently 10.261% of BELLUS Health stocks are held by insiders and 90.409% by institutions. How many people work for BELLUS Health?
Latest data suggests 74 work at BELLUS Health. When does the fiscal year end for BELLUS Health?
BELLUS Health's fiscal year ends in December. Where is BELLUS Health based?
BELLUS Health's address is: 275 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4A7 What is BELLUS Health's ISIN number?
BELLUS Health's international securities identification number is: CA07987C2040

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.